Evidence map›Paper›PMID 35908135›Full record

ReviewDrugs & aging2022

Hormonal Agents for the Treatment of Depression Associated with the Menopause.

Megan Herson, Jayashri Kulkarni

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Drugs & aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07165964 (Nursing Interventions to Enhance Positive Mental Health and Self Care in Women During the Climacteric), which is not on this map. Cited by 52 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 7 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07165964 narecruitingnot on this mapstarted 2025, after this paper: background citation

Nursing Interventions to Enhance Positive Mental Health and Self Care in Women During the Climacteric

TypeinterventionalSponsorUniversity of BarcelonaRan2025 to 2026Enrolled250ConditionsClimacteric Symptoms, Climactericum, Self CareArmsPersonal interventions in Climateric
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 7 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. ADHD and Sex Hormones in Females: A Systematic Review.Journal of attention disorders · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Brazilian Guideline on Menopausal Cardiovascular Health - 2024.Arquivos brasileiros de cardiologia · 2024
    Guideline
  5. Pooled it
  6. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review.Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2023
    Pooled it
  7. Menopause and suicide: A systematic review.Women's health (London, England)
    Pooled it
  8. Trial
  9. Trial
  10. Menopausal Suicidality and Fragmented Care: A Qualitative Study of Carer and Clinician Perspectives.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  11. Review
  12. Review
  13. Cognitive dysfunction in women with theJournal of Alzheimer's disease : JAD · 2026
    Article
  14. Review
  15. Article
  16. Gender Differences and Comorbidities in Major Depression.Advances in experimental medicine and biology · 2026
    Review
  17. Review
  18. Menopause and Mental Health.Advances in therapy · 2026
    Review
  19. Article
  20. Depression Symptom Trajectories in Mothers With the FMR1 Premutation Vary by CGG Repeat Length: A Longitudinal Study of 73 Women Spanning 20-75 Years of Age.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Megan HersonFaculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Jayashri KulkarniDepartment of Psychiatry, Central Clinical School, Monash University, Melbourne, VIC, Australia. jayashri.kulkarni@monash.edu.ORCID http://orcid.org/0000-0002-3875-5623
Monash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perimenopause marks the transition from a woman's reproductive stage to menopause. Usually occurring between 42 and 52 years of age, it is determined clinically by the onset of irregular menstrual cycles or variable cycle lengths. Women are at an increased risk of depression and anxiety during perimenopause and the menopausal transition. Depressive symptoms experienced in perimenopause are often more severe compared to pre- and post-menopause. During menopausal transition, the impact of fluctuating estrogen in the central nervous system (CNS) can have negative psychological effects for some women. Traditional first-line management of menopausal depression involves antidepressants, with modest outcomes. The positive effects of estrogen treatment in the CNS are becoming increasingly recognised, and hormonal therapy (HT) with estrogen may have a role in the treatment of menopausal depression. In this review we will outline the prevalence, impact and neurochemical basis of menopausal-associated depression, as well as hormone-based approaches that have increasing promise as effective treatments.

Indexed as

DepressionMenopauseAntidepressive AgentsEstrogensFemaleHumansPerimenopauseAntidepressive AgentsEstrogens

Identifiers

PMID35908135
PMCPMC9355926
OpenAlexW4288902457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.